GALECTIN THERAPEUTICS INC. Investing Cash Flow
GALECTIN THERAPEUTICS INC. (GALT) reported Investing Cash Flow of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-03-31
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities for the quarter ending 2014-03-31 was -$400.00K.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities for the quarter ending 2013-06-30 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities for fiscal 2025 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities for fiscal 2024 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities for fiscal 2023 was $0.00.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) investing activities for fiscal 2022 was $0.00.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 132 month | Net Cash Provided by (Used in) Investing Activities 135 month | Net Cash Provided by (Used in) Investing Activities 138 month | Net Cash Provided by (Used in) Investing Activities 141 month | Net Cash Provided by (Used in) Investing Activities 144 month | Net Cash Provided by (Used in) Investing Activities 147 month | Net Cash Provided by (Used in) Investing Activities 150 month | Net Cash Provided by (Used in) Investing Activities 153 month | Net Cash Provided by (Used in) Investing Activities 156 month | Net Cash Provided by (Used in) Investing Activities 159 month | Net Cash Provided by (Used in) Investing Activities 162 month | Net Cash Provided by (Used in) Investing Activities 165 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 | |||||||||||||||
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 | |||||||||||||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 | |||||||||||||||
| 2022-12-31 | $0.00 10-K · filed 2024-03-29 | |||||||||||||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | |||||||||||||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 | |||||||||||||||
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 | |||||||||||||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-06 | |||||||||||||||
| 2014-03-31 | -$400.00K 10-Q · filed 2014-05-13 | -$400.00K derived: sum of 2 quarters · filed 2014-05-13 | -$400.00K derived: sum of 3 quarters · filed 2014-05-13 | -$400.00K derived: sum of 4 quarters · filed 2014-05-13 | -$1.24M 10-Q · filed 2014-05-13 | |||||||||||
| 2013-12-31 | $0.00 derived: 10-K 162 month − 10-Q 159 month · filed 2014-03-21 | $0.00 derived: sum of 2 quarters · filed 2014-03-21 | $0.00 derived: sum of 3 quarters · filed 2014-03-21 | $0.00 derived: sum of 4 quarters · filed 2014-03-21 | -$835.00K 10-K · filed 2014-03-21 | |||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 159 month − 10-Q 156 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 derived: sum of 3 quarters · filed 2013-11-12 | $56.00K derived: sum of 4 quarters · filed 2014-03-21 | -$835.00K 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 156 month − 10-Q 153 month · filed 2013-08-14 | $0.00 derived: sum of 2 quarters · filed 2013-08-14 | $56.00K derived: sum of 3 quarters · filed 2014-03-21 | $64.00K derived: sum of 4 quarters · filed 2014-03-21 | -$835.00K 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 153 month − 10-K 150 month · filed 2013-05-10 | $56.00K derived: sum of 2 quarters · filed 2014-03-21 | $64.00K derived: sum of 3 quarters · filed 2014-03-21 | $64.00K derived: sum of 4 quarters · filed 2014-03-21 | -$835.00K 10-Q · filed 2013-05-10 | |||||||||||
| 2012-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $64.00K derived: sum of 2 quarters · filed 2014-03-21 | $64.00K derived: sum of 3 quarters · filed 2014-03-21 | $64.00K 10-K · filed 2014-03-21 | -$835.00K 10-K · filed 2013-03-29 | |||||||||||
| 2012-09-30 | $8.00K derived: 10-Q 147 month − 10-Q 144 month · filed 2012-11-09 | $8.00K derived: sum of 2 quarters · filed 2012-11-09 | $8.00K 10-Q · filed 2013-11-12 | $3.00K derived: sum of 4 quarters · filed 2013-03-29 | -$891.00K 10-Q · filed 2012-11-09 | |||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 144 month − 10-Q 141 month · filed 2012-08-10 | $0.00 derived: sum of 2 quarters · filed 2012-08-10 | -$5.00K derived: sum of 3 quarters · filed 2013-03-29 | -$10.00K derived: sum of 4 quarters · filed 2013-03-29 | -$899.00K 10-Q · filed 2012-08-10 | |||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 141 month − 10-K 138 month · filed 2012-05-11 | -$5.00K derived: sum of 2 quarters · filed 2013-03-29 | -$10.00K derived: sum of 3 quarters · filed 2013-03-29 | -$899.00K 10-Q · filed 2012-05-11 | ||||||||||||
| 2011-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$10.00K derived: sum of 2 quarters · filed 2013-03-29 | -$15.00K 10-K · filed 2013-03-29 | -$899.00K 10-K · filed 2012-03-30 | ||||||||||||
| 2011-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$10.00K 10-Q · filed 2012-11-09 | -$894.00K 10-Q · filed 2011-11-10 | |||||||||||||
| 2011-06-30 | -$5.00K 10-Q · filed 2012-08-10 | -$889.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |